Astera Labs (NASDAQ:ALAB – Get Free Report) was upgraded by research analysts at Northland Securities from a “market perform” rating to an “outperform” rating in a report released on Wednesday, MarketBeat.com reports. The brokerage currently has a $315.00 target price on the stock. Northland Securities‘s target price would indicate a potential upside of 34.83% from the stock’s current price.
Other equities research analysts have also issued reports about the company. Needham & Company LLC lifted their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Roth Capital reiterated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. UBS Group restated a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Weiss Ratings cut shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Twelve research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $332.37.
Check Out Our Latest Analysis on ALAB
Astera Labs Stock Performance
ALAB stock opened at $233.62 on Wednesday. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The business’s 50 day moving average price is $306.13 and its two-hundred day moving average price is $255.53. The company has a market capitalization of $40.53 billion, a price-to-earnings ratio of 115.65 and a beta of 3.85.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business’s revenue was up 153.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 EPS. Sell-side analysts forecast that Astera Labs will post 2.71 earnings per share for the current year.
Insider Transactions at Astera Labs
In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. The trade was a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 408,558 shares of company stock worth $127,306,034. Company insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
Several institutional investors and hedge funds have recently modified their holdings of the stock. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the 2nd quarter worth approximately $25,000. Archer Investment Corp bought a new stake in Astera Labs during the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs during the second quarter valued at approximately $35,000. Continuum Advisory LLC purchased a new position in Astera Labs during the second quarter valued at approximately $37,000. Finally, GK Wealth Management LLC bought a new position in shares of Astera Labs in the third quarter worth approximately $29,000. 60.47% of the stock is currently owned by institutional investors.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs reported record Q3 revenue of $584.9 million, up 49% quarter over quarter and 154% year over year. Adjusted earnings of $1.32 per share beat the $1.19 consensus estimate, as did revenue versus expectations of $550.78 million. Astera Labs Reports Third Quarter 2026 Financial Results
- Positive Sentiment: Growth was led by the Scorpio fabric-switch family, now Astera Labs’ largest product line, with volume production of the Scorpio X-Series 320-lane switch. The company also expanded products for memory, optical and copper connectivity, and rack-scale AI systems—supporting its opportunity in AI infrastructure. Q3 2026 Earnings Call Highlights
- Positive Sentiment: Reports said the company’s forward guidance also topped estimates, adding to the earnings beat and potentially reinforcing expectations for continued demand. Astera Labs Q3 Results and Guidance
- Negative Sentiment: The results arrive after a sharp retreat: a recent report said ALAB had fallen about 54% from its year-to-date high and broken below key support. That weakness may keep volatility elevated and leave investors focused on whether earnings growth can restore confidence. Astera Labs Stock and Key Support
Astera Labs Company Profile
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
Further Reading
- Five stocks we like better than Astera Labs
- Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
